GOLDMAN SACHS GROUP INC - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 37 filers reported holding GLYCOMIMETICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q3 2023$1,191,741
-12.6%
794,494
+1.4%
0.00%
Q2 2023$1,363,692
+20.0%
783,731
-13.1%
0.00%
Q1 2023$1,136,383
+454.2%
901,891
+1232.8%
0.00%
Q4 2022$205,043
+272.8%
67,671
+75.6%
0.00%
Q4 2021$55,000
-5.2%
38,533
+46.1%
0.00%
Q3 2021$58,000
-79.7%
26,375
-78.6%
0.00%
Q2 2021$286,000
+172.4%
123,407
+253.3%
0.00%
Q1 2021$105,000
-44.7%
34,930
-30.8%
0.00%
Q4 2020$190,000
-29.4%
50,508
-42.3%
0.00%
Q3 2020$269,000
-27.9%
87,526
-12.0%
0.00%
Q2 2020$373,000
+70.3%
99,429
+3.6%
0.00%
Q1 2020$219,000
-47.4%
95,956
+22.0%
0.00%
Q4 2019$416,000
-18.8%
78,665
-33.8%
0.00%
Q3 2019$512,000
-22.7%
118,876
+114.1%
0.00%
Q2 2019$662,000
+16.8%
55,529
+22.0%
0.00%
Q1 2019$567,000
+46.1%
45,508
+11.1%
0.00%
Q4 2018$388,000
-64.4%
40,979
-45.9%
0.00%
Q3 2018$1,090,000
+210.5%
75,691
+248.2%
0.00%
Q2 2018$351,000
-90.5%
21,739
-90.4%
0.00%
-100.0%
Q1 2018$3,694,000
+94.4%
227,617
+101.1%
0.00%
Q4 2017$1,900,000
+96.9%
113,166
+30.9%
0.00%
Q2 2017$965,000
+51.0%
86,430
-1.6%
0.00%
Q2 2016$639,000
+292.0%
87,861
+221.6%
0.00%
Q1 2016$163,000
-48.9%
27,321
-51.1%
0.00%
Q4 2015$319,000
+4.9%
55,842
+2.9%
0.00%
Q3 2015$304,000
-48.4%
54,282
-26.8%
0.00%
Q2 2015$589,000
-4.4%
74,134
+0.1%
0.00%
Q1 2015$616,000
-5.1%
74,041
-17.8%
0.00%
Q4 2014$649,000
-2.1%
90,126
-5.7%
0.00%
Q3 2014$663,000
-21.9%
95,556
-5.1%
0.00%
Q2 2014$849,000
-51.6%
100,667
-6.3%
0.00%
-100.0%
Q1 2014$1,754,000107,4060.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
BVF INC/IL 7,361,801$31,729,0003.33%
NEA Management Company, LLC 9,089,041$39,174,0003.24%
Camber Capital Management LP 3,500,000$15,085,0000.79%
Redmile Group, LLC 1,997,647$8,610,0000.29%
Alambic Investment Management, L.P. 41,698$180,0000.14%
CAXTON CORP 26,575$115,0000.13%
PRENTISS SMITH & CO INC 17,000$73,0000.05%
Virtus ETF Advisers LLC 22,580$97,0000.02%
AXA S.A. 1,825,738$7,868,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 30,000$129,0000.01%
View complete list of GLYCOMIMETICS INC shareholders